{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:30:19Z","timestamp":1793773819810,"version":"4.6.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1097\/cji.0b013e318194a6e8","type":"journal-article","created":{"date-parts":[[2009,2,18]],"date-time":"2009-02-18T07:22:51Z","timestamp":1234941771000},"page":"169-180","source":"Crossref","is-referenced-by-count":273,"title":["Manufacturing Validation of Biologically Functional T Cells Targeted to CD19 Antigen for Autologous Adoptive Cell Therapy"],"prefix":"10.1097","volume":"32","author":[{"given":"Daniel","family":"Hollyman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Stefanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Przybylowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Bartido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriana","family":"Borquez-Ojeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Capacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Olszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Hosey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Sadelain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renier J.","family":"Brentjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Rivi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210219","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00062752-200307000-00008","article-title":"Advances in the therapy of chronic lymphocytic leukemia","volume":"10","author":"Johnson","year":"2003","journal-title":"Curr Opin Hematol"},{"key":"R2-9-20210219","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2141.1988.tb02488.x","article-title":"Relapse after allogeneic bone marrow transplantation for acute leukaemia: a survey by the E.B.M.T. of 117 cases","volume":"70","author":"Frassoni","year":"1988","journal-title":"Br J Haematol"},{"key":"R3-9-20210219","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2141.1991.tb08083.x","article-title":"Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A report by the EBMT leukaemia working party","volume":"79","author":"Barrett","year":"1991","journal-title":"Br J Haematol"},{"key":"R4-9-20210219","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1046\/j.1365-2141.2000.01851.x","article-title":"Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the societe francaise de greffe de moelle (SFGM)","volume":"108","author":"Michallet","year":"2000","journal-title":"Br J Haematol"},{"key":"R5-9-20210219","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1200\/JCO.2005.00.240","article-title":"Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma","volume":"23","author":"Dudley","year":"2005","journal-title":"J Clin Oncol"},{"key":"R6-9-20210219","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.1129003","article-title":"Cancer regression in patients after transfer of genetically engineered lymphocytes","volume":"314","author":"Morgan","year":"2006","journal-title":"Science"},{"key":"R7-9-20210219","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1182\/blood-2007-12-128843","article-title":"Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells","volume":"112","author":"Till","year":"2008","journal-title":"Blood"},{"key":"R8-9-20210219","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1056\/NEJMoa0800251","article-title":"Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1","volume":"358","author":"Hunder","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"R9-9-20210219","doi-asserted-by":"crossref","first-page":"14639","DOI":"10.1073\/pnas.0405730101","article-title":"Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes","volume":"101","author":"Rosenberg","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"R10-9-20210219","doi-asserted-by":"crossref","first-page":"16168","DOI":"10.1073\/pnas.242600099","article-title":"Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells","volume":"99","author":"Yee","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R11-9-20210219","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nm827","article-title":"Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15","volume":"9","author":"Brentjens","year":"2003","journal-title":"Nat Med"},{"issue":"18","key":"R12-9-20210219","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1158\/1078-0432.CCR-07-0674","article-title":"Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts","volume":"13","author":"Brentjens","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R13-9-20210219","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.1073\/pnas.92.15.6733","article-title":"Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells","volume":"92","author":"Riviere","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"R14-9-20210219","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nbt0102-70","article-title":"Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta \/CD28 receptor","volume":"20","author":"Maher","year":"2002","journal-title":"Nat Biotechnol"},{"key":"R15-9-20210219","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/nm1676","article-title":"T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection","volume":"13","author":"Stephan","year":"2007","journal-title":"Nat Med"},{"key":"R16-9-20210219","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/blood-2005-08-3373","article-title":"A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3\/CD28 costimulation","volume":"107","author":"Porter","year":"2006","journal-title":"Blood"},{"key":"R17-9-20210219","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.4049\/jimmunol.174.4.2366","article-title":"In vitro engagement of CD3 and CD28 corrects T cell defects in chronic lymphocytic leukemia","volume":"174","author":"Bonyhadi","year":"2005","journal-title":"J Immunol"},{"key":"R18-9-20210219","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1080\/14653240410005348","article-title":"GMP production and testing of Xcellerated T Cells for the treatment of patients with CLL","volume":"6","author":"Hami","year":"2004","journal-title":"Cytotherapy"},{"key":"R19-9-20210219","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.bmt.1704317","article-title":"Molecular remission of CML after autotransplantation followed by adoptive transfer of costimulated autologous T cells","volume":"33","author":"Rapoport","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"R20-9-20210219","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1182\/blood-2003-01-0095","article-title":"Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed\/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation","volume":"102","author":"Laport","year":"2003","journal-title":"Blood"},{"key":"R21-9-20210219","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/nm1310","article-title":"Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer","volume":"11","author":"Rapoport","year":"2005","journal-title":"Nat Med"},{"key":"R22-9-20210219","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nm0102-47","article-title":"Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection","volume":"8","author":"Levine","year":"2002","journal-title":"Nat Med"},{"key":"R23-9-20210219","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1089\/scd.1.1998.7.437","article-title":"Large-scale production of CD4+ T cells from HIV-1-infected donors after CD3\/CD28 costimulation","volume":"7","author":"Levine","year":"1998","journal-title":"J Hematother"},{"key":"R24-9-20210219","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.ymthe.2004.03.005","article-title":"Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load","volume":"9","author":"Humeau","year":"2004","journal-title":"Mol Ther"},{"key":"R25-9-20210219","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00002371-200409000-00010","article-title":"Optimization of human T-cell expansion ex vivo using magnetic beads conjugated with anti-CD3 and anti-CD28 antibodies","volume":"27","author":"Kalamasz","year":"2004","journal-title":"J Immunother"},{"key":"R26-9-20210219","first-page":"41","article-title":"Cell isolation and expansion using Dynabeads","volume":"106","author":"Neurauter","year":"2007","journal-title":"Adv Biochem Eng Biotechnol"},{"key":"R27-9-20210219","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1016\/j.ymthe.2006.08.322","article-title":"CD19-targeted normal and CLL patient T Cells expanded with Beads can eradicate systemic tumors in vivo","volume":"13","author":"Stefanski","year":"2006","journal-title":"Mol Ther"},{"key":"R28-9-20210219","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.gt.3302648","article-title":"Production scale-up and validation of packaging cell clearance of clinical-grade retroviral vector stocks produced in cell factories","volume":"13","author":"Przybylowski","year":"2006","journal-title":"Gene Ther"},{"key":"R29-9-20210219","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/CJI.0b013e318052e1f4","article-title":"Manufacturing of large numbers of patient-specific T cells for adoptive immunotherapy: an approach to improving product safety, composition, and production capacity","volume":"30","author":"Tran","year":"2007","journal-title":"J Immunother"},{"key":"R30-9-20210219","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1089\/hum.2007.088","article-title":"Multifactorial optimization of gammaretroviral gene transfer into human T lymphocytes for clinical application","volume":"18","author":"Quintas-Cardama","year":"2007","journal-title":"Hum Gene Ther"},{"key":"R31-9-20210219","article-title":"Center for Biologics Evaluation and Research. Food and Drug Administration, US Department of Health and Human Services","year":"2006"},{"key":"R33-9-20210219","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/14653240802075476","article-title":"A multicenter comparison study between the Endosafe PTS rapid-release testing system and traditional methods for detecting endotoxin in cell-therapy products","volume":"10","author":"Gee","year":"2008","journal-title":"Cytotherapy"},{"key":"R34-9-20210219","doi-asserted-by":"crossref","first-page":"8941","DOI":"10.1073\/pnas.86.22.8941","article-title":"Interaction of Staphylococcus aureus toxin \u201csuperantigens\u201d with human T cells","volume":"86","author":"Choi","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"R35-9-20210219","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/eji.1830220522","article-title":"An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29\/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction","volume":"22","author":"Genevee","year":"1992","journal-title":"Eur J Immunol"},{"key":"R36-9-20210219","first-page":"109a","article-title":"A phase I\/II trial of Xcellerated T cells in patients with chronic lymphocytic leukemia","volume":"102","author":"Kipps","year":"2003","journal-title":"Blood"},{"key":"R37-9-20210219","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"R38-9-20210219","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.0105-2896.2006.00391.x","article-title":"CD8+ T-cell memory in tumor immunology and immunotherapy","volume":"211","author":"Klebanoff","year":"2006","journal-title":"Immunol Rev"},{"key":"R39-9-20210219","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1172\/JCI32103","article-title":"Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates","volume":"118","author":"Berger","year":"2008","journal-title":"J Clin Invest"}],"container-title":["Journal of Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CJI.0b013e318194a6e8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:37:52Z","timestamp":1786037872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002371-200902000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/cji.0b013e318194a6e8","relation":{},"ISSN":["1524-9557"],"issn-type":[{"value":"1524-9557","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}